Filtered news list testing
List of Reports
.pdf
Revenue At September 30, 2024
.pdf
09/26/2024 - 2024 Half-year results (Presentation)
.pdf
09/26/2024 - Half-year financial report 2024
.pdf
09/25/2024 - H1 2024 results
.pdf
07/25/2024 - H1 2024 revenue
.pdf
04/25/2024 - Q1 2024 revenue
.pdf
04/03/2024 - Universal Registration Document 2023
.pdf
03/21/2024 - 2023 Full-year results (Presentation)
Single report testing
.pdf
test report fabien V 09-07
Separator
Filtered images
Discover the latest news of Guerbet
Latest news
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT
2024 revenue
2024 revenue
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging